Pura Vida Investments’s CervoMed CRVO Stock Holding History

Pura Vida Investments’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-74	Closed	-$193K	–	83
2017 Q2	$193K	Buy	+74	New	+$238K	0.08%	64

Other funds holding CRVO

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Signature Financial Management Norfolk, Virginia $416M AUM 8.59% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pura Vida Investments's CRVO Position: Q3 2017 in Review

Pura Vida Investments sold out of CervoMed (CRVO) in Q3 2017, closing a stake of 74 shares — an estimated $193K sold.

Pura Vida Investments first reported a position in CRVO in Q2 2017 and held it in 1 quarter. The position peaked at $193K in Q2 2017. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2017.

Pura Vida Investments reported no remaining CervoMed position as of Q3 2017 after selling out during the quarter.
Pura Vida Investments sold 74 CervoMed shares in Q3 2017, an estimated $193K.
Pura Vida Investments first reported a position in CervoMed in Q2 2017 and held it in 1 quarter.
Pura Vida Investments's CervoMed position peaked at $193K in Q2 2017.
12 funds tracked by Wall St. Rank held CervoMed as of Q3 2017.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.